Evidentli is a software company that specialises in real-world clinical data. Translating the previously incomprehensible, bringing together the historically fragmented, our mission is to empower the world's communities to advance healthcare through data.
Alison brings over 16 years of experience in the Australian Healthcare start-up sector working on family office, venture capital investing and establishing healthcare funds. She is on the board and Research Advisory Committee of the National Foundation for Medical Research and Innovation.
Blackford is a physician and health informatics innovator committed to healthcare transformation. As one of the pioneers of digital health, Blackford served on the AHRQ evidence-based Care Transformation Support (ACTS) Roadmap working group and served as Chair of the Steering Committee for the Patient-centered Clinical Decision Support Learning Network. He is past Chairman of the Board of Directors of the American Medical Informatics Association (AMIA), the Healthcare Information Management and Systems Society (HIMSS), and the Computer-based Patient Record Institute (CPRI).
Davera is a nurse informatician and prior to joining the Company she was the HL7 Terminology Service Management Group co-chair and the director of terminology management at the Johns Hopkins University. She has over three decades of experience in health systems analysis and implementing information technology, terminologies and health data standards in human and population health research.
Enrico is a pioneer and key opinion leader in health informatics globally and in Australia. He is the Director for the Centre for Health Informatics and NHMRC Centre for Research Excellence in eHealth at Macquarie University, the founder of the Australian College of Health Informatician and the author of the Guide to Health Informatics. Enrico is one of only 10 past François Grémy Award of Excellence recipients conferred by the International Medical Informatics Association.
Grahame is the Inventor and project lead for data interoperability standard HL7/FHIR. Grahame is the world leading expert on clinical data interoperability, whose work is connecting USA, European and other healthcare data systems.
Greg brings a wealth of experience as a senior enterprise software executive with a track record of scaling global organisations. He is a former CEO of a high growth cloud software company and General Manager of an ASX listed health informatics company, and has previously held executive roles at Microsoft and Apple. Greg holds a bachelor’s degree in science from the University of Connecticut and master’s degree in business administration from the University of New South Wales.
Guy is the Founder and Chief Scientific Officer of Evidentli, and the inventor of Evidentli’s technology. Originally an AI expert from Silicon Valley, Guy has specialized in biomedical AI since 2006, and published over a hundred academic papers. Guy is also an associate editor at two of the three most important scientific journals in digital health: Journal of Biomedical Informatics (Elsevier) and JMIR (JMIR Publishing). Guy also co-leads the FHIR to OMOP harmonization working group at HL7 and OHDSI, is a Fellow of the Australasian Institute for Digital Health, and is a co-founder of the International Collaboration for Automation of Systematic Reviews (ICASR). Guy holds an Adjunct Fellow position at the Centre for Health Informatics at Macquarie University.
Ken directs the Computational Health Informatics Program at Boston Children's Hospital and is the Donald A.B. Lindberg Professor of Pediatrics and Biomedical Informatics at Harvard University. He is trained as a pediatrician and pediatric emergency physician and a pioneer in biomedical informatics. Dr. Mandl is a recipient of the Presidential Early Career Award for Scientists and Engineers, the Donald A.B. Lindberg Award for Innovation in Informatics and the Clifford A. Barger Award for top mentors at Harvard Medical School.
Paul is the director of the Institute for Evidence Based Healthcare, Bond University. His team is building capacity in health services research and does applied research that can be used to improve the efficiency and organisation of health services. Paul is the former director of the Centre for Evidence Based Medicine at Oxford University. He is an NHMRC Senior Research Fellow and the author of many evidence based medicine standards.
.png)
30 years investment and financial industry experience across venture capital, investment banking, funds management, M&A, corporate and strategic advisory with Goldman Sachs, GS JBWere, Commercial Union Asset Management, Investment Partner at Real VC, CEO Asia Principal Capital, Trustee HEAL Partners Funds. AFSL holder and Compliance Officer for Factory Capital, RealVC and Asia Principal Capital.
Susan is the former CEO of Therapeutic Guidelines: Australia’s biggest publisher of evidence-based recommendations for clinical practice and held executive and change management roles at the National Institute of Clinical Studies, National Health and Medical Research Council. She was awarded an Australia Day Medallion in recognition of her work in closing evidence-practice gaps in Australian health care settings.
Tom spent the first 20 years of his career at IBM in a variety of sales and sales leadership roles. Tom covered markets for SMB to the Global 500. At the time of his departure Tom was the Director of Sales for IBM Credit Corporation with responsibility for a leasing portfolio in excess of $1B. Tom moved to Dell in 2000. His responsibilities included Area VP of Sales for the Global 500, VP of Sales for the Corporate Accounts Division, VP of Sales for Dell Financial Services and VP of Americas Sales for Dell Services. Since his departure from Dell in 2012 Tom has worked as a large deal and Executive Coach for Revenue Storm.
Integrity is fundamental to who we are. We are truthful, accountable and self-aware. We accept the facts regardless of how difficult they may be.
We believe that a team diverse in background, perspective and lived experience is essential to our success. We respect each other and are deliberate in fostering an inclusive and flexible work environment.
We are relentless in pursuit of innovation that will accelerate scientific advancement. We do our best work because we are committed to moving healthcare forward, and we do so without ego.
We embrace the impossible. We have courage to speak up, question the status quo, overcome new and unique challenges, and learn along the way.
At Evidentli, we are dedicated to building a diverse, authentic workplace. We empower our team with flexible work arrangements and the autonomy to do their best work in a supportive environment. We believe strongly in professional growth and development. Our staff learn new skills and gain invaluable experience in both their field of expertise, and other aspects of the business.
All full time employees at Evidentli are entitled to participate in our generous Employee Stock Option Programme and to take part in the success of the company.
